Cancer Trial

Carina receives ‘Safe to proceed’ letter for Phase 1/2a clinical trial of CNA3103

2023-05-02T13:29:34+09:30January 24th, 2023|Cancer Trial, News|

PRESS RELEASE Tuesday, January 24, 2023 Carina Biotech Receives FDA “Safe to Proceed” Letter for IND Application for Phase 1/2a Clinical Trial of LGR5-Targeted CAR-T Cell Therapy Candidate for Treatment

Go to Top